Home  »  Markets   »  Amedisys Inc. (AMED) Review – Making Smarter...

Amedisys Inc. (AMED) Review – Making Smarter Decisions

Amedisys Inc. (NASDAQ: AMED) is -7.29% lower on its value in year-to-date trading and has touched a low of $76.93 and a high of $179.91 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The AMED stock was last observed hovering at around $78.97 in the last trading session, with the day’s loss setting it -1.52%.

Currently trading at $77.45, the stock is -13.63% and -13.84% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.64 million and changing -1.92% at the moment leaves the stock -24.30% off its SMA200. AMED registered -45.96% loss for a year compared to 6-month loss of -35.61%.

From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio

The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.

Get our free report, "Top 5 AI Stocks to Buy for 2023".


The stock witnessed a -17.56% gain in the last 1 month and extending the period to 3 months gives it a -9.01%, and is -8.70% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.74% over the week and 3.72% over the month.

Amedisys Inc. (AMED) has around 20000 employees, a market worth around $2.52B and $2.22B in sales. Current P/E ratio is 21.32 and Fwd P/E is 16.25. Profit margin for the company is 5.30%. Distance from 52-week low is 0.67% and -56.95% from its 52-week high. The company has generated returns on investments over the last 12 months (9.30%).

Amedisys Inc. (AMED) Analyst Forecasts

Amedisys Inc. is expected to release its quarterly report on 05/09/2023.The EPS is expected to shrink by -42.70% this year

Amedisys Inc. (AMED) Top Institutional Holders

The shares outstanding are 32.51M, and float is at 31.91M with Short Float at 6.54%.

Amedisys Inc. (AMED) Insider Activity

A total of 11 insider transactions have happened at Amedisys Inc. (AMED) in the last six months, with sales accounting for 6 and purchases happening 5 times. The most recent transaction is an insider sale by North Michael Paul, the company’s Chief Information Officer. SEC filings show that North Michael Paul sold 5,908 shares of the company’s common stock on Mar 03 at a price of $86.43 per share for a total of $0.51 million. Following the sale, the insider now owns 4164.0 shares.

Amedisys Inc. disclosed in a document filed with the SEC on Jun 23 that Bohnert Denise M. (Chief Compliance Officer) sold a total of 557 shares of the company’s common stock. The trade occurred on Jun 23 and was made at $115.00 per share for $64055.0. Following the transaction, the insider now directly holds 11850.0 shares of the AMED stock.

Still, SEC filings show that on Mar 29, Kemmerly David L () disposed off 2,500 shares at an average price of $177.31 for $0.44 million. The insider now directly holds 16,336 shares of Amedisys Inc. (AMED).

Amedisys Inc. (AMED): Who are the competitors?

The company’s main competitors (and peers) include Chemed Corporation (CHE) that is trading 8.90% up over the past 12 months and National HealthCare Corporation (NHC) that is -17.12% lower over the same period.

Most Popular

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Related Posts